Holen Sie sich die Stockscreener-App
1,128.37
0.94%
4.4578
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
BMO reiterates Eli Lilly stock rating on incretin growth outlook - Investing.com
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031 - The Motley Fool
What Is Shaping Interest in Eli Lilly Stock? (NYSE:LLY) - Kalkine Media
Eli Lilly 'Sabotaged' Rezpeg's Development, Nektar Tells Jury - Law360
Eli Lilly lawsuit against weight-loss drug seller gets another shave - Courthouse News
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years - Benzinga
Advanced Micro Devices Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Eli Lilly (NYSE:LLY) Heads Into Conference Season With A Broadening Pipeline - Kalkine Media
ELI LILLY Executive Vice President Eric Dozier Retains 14,239 Shares Following Gift Transaction - Kalkine Media
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - The Motley Fool
Lilly fighting black market for its next obesity drug - The Indiana Lawyer
Eli Lilly (NYSE:LLY): Can New FDA Approvals Fuel Growth? - Kalkine Media
Why Is Eli Lilly Stock Falling Tuesday? - Benzinga
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other. - Barchart.com
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock? - Yahoo Finance
Eli Lilly and Company (LLY) Stock Analysis: Exploring a Potential 14.46% Upside in the Healthcare Giant - DirectorsTalk Interviews
Eli Lilly expands US pharmaceutical manufacturing with over US$50bn investment - Scientist Live
Eli Lilly’s $100B incretin opportunity: Is more upside coming? - Investing.com
Lilly invests SGD $42M in new Digital Health Hub in Singapore - Singapore Economic Development Board (EDB)
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 Years - The Motley Fool
Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does. - The Motley Fool
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Lilly looks beyond obesity with $2.88B autoimmune buyout - thestreet.com
The Oral GLP-1 Tracker: Novo's Wegovy pill, Lilly's Foundayo grow scripts - fiercepharma.com
DRUGS AND BIOLOGICS—5th Cir.: Fifth Circuit upholds FDA's removal of tirzepatide from drug shortage list, rejecting compounders' APA challenges - VitalLaw.com
Eli Lilly and Company $LLY Shares Bought by BNP Paribas - insurancenewsnet.com
Eli Lilly Just Announced a Major Acquisition. Here's What It Means. - The Motley Fool
Eli Lilly’s Foundayo Launches in UK Amid Counterfeit Risks - healthcare-digital.com
Lilly to acquire Merida Biosciences for up to $2.875bn - Manufacturing Chemist
Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity - MarketBeat
JPMorgan reiterates Eli Lilly stock rating on incretin growth - Investing.com
Smart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore - Singapore Economic Development Board (EDB)
This New Zepbound Study Could Be Great News for Eli Lilly Investors - The Motley Fool
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal - Yahoo Finance
Lilly to acquire biotechnology company for $2.8B - dailyjournal.net
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors - Endpoints News
BMO reiterates Eli Lilly stock Outperform on Merida acquisition - Investing.com
Merida Biosciences Acquisition by Eli Lilly for Up to $2.875 Bil - GuruFocus
Eli Lilly to buy Merida Biosciences for up to $2.88B, expanding immunology pipeline - Yahoo! Finance Canada
Lilly snags another Massachusetts biotech as local headcount surges past 1,400 - The Business Journals
Eli Lilly to Acquire Merida Biosciences for Up to $2.875 Billion - citybiz
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion - WSJ
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases - Eli Lilly
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes - Eli Lilly and Company
Can Eli Lilly's Oncology Portfolio Drive Growth Beyond GLP-1 Drugs? - Yahoo Finance
Lilly(Eli) & Co (LLY) Futures: Prices, Contracts & Specs - stocktwits.com
Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement - tradingkey.com
Eli Lilly launches oral weight-loss drug Foundayo in UK - Reuters
Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY) - Seeking Alpha
Novo Nordisk: The Pill That Could Close The Gap With Lilly (NYSE:NVO) - Seeking Alpha
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 5 Years - Benzinga
Eli Lilly and Company (NYSE:LLY) Shares Up 1%Here's What Happened - MarketBeat
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance
Eli Lilly will replace lost insulin after Indiana storms - nwitimes.com
Amplitude Therapeutics and Lilly Partner to Advance Trans-Amplifying RNA Vaccine Platform for Infectious Disease - BioPharm International
Stock Split Watch: Is Eli Lilly (LLY) Stock Next? - The Motley Fool
Lilly to work with Boston-based firm to develop RNA vaccine platform - dailyjournal.net
0.15%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):